Detalhe da pesquisa
1.
Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3.
Hum Mol Genet;
26(20): 3883-3894, 2017 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29016851
2.
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
N Engl J Med;
364(23): 2218-26, 2011 Jun 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21651393
3.
Mitotane (op'DDD) restores growth and puberty in nine children with Cushing's disease.
Endocr Connect;
7(12): 1280-1287, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30352417
4.
Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance.
Mol Cell Endocrinol;
442: 1-11, 2017 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27908835
5.
Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis.
J Bone Miner Res;
32(2): 333-346, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27589370
6.
Ketoconazole in Cushing's disease: is it worth a try?
J Clin Endocrinol Metab;
99(5): 1623-30, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24471573
7.
Use of neurally adjusted ventilator assist in postsurgical hemidiaphragmatic paralysis.
Arch Dis Child Fetal Neonatal Ed;
103(1): F86-F87, 2018 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29092910